Richard G. Langley
- Dermatology top 0.01%
- Dermatology and Skin Diseases 120
- Immunology top 0.05%
- Psoriasis: Treatment and Pathogenesis 181
- Rheumatology top 0.1%
- Hematology top 0.2%
- Autoimmune and Inflammatory Disorders Research 21
- Immunology and Allergy top 0.5%
- Food Allergy and Anaphylaxis Research 17
-
- Asthma and respiratory diseases 50
-
- Autoimmune Bullous Skin Diseases 41
-
- Health Systems, Economic Evaluations, Quality of Life 29
-
- Pharmaceutical studies and practices 26
- Co-authors
- Kim PappKristian ReichMark LebwohlKenneth B. GordonCraig L. LeonardiCharles N. EllisGerald G. KruegerAlan Menter
- Cited by
- DermatologyImmunologyRheumatology
- Partner nations
- CanadaUnited StatesGermany
In The Last Decade
Richard G. Langley
241 papers receiving 18.6k citations
Hit Papers
Peers
Comparison fields: 5 of 154
- Dermatology 9.6k
- Immunology 14.7k
- Rheumatology 3.4k
- Hematology 2.3k
- Immunology and Allergy 1.2k
Countries citing papers authored by Richard G. Langley
This map shows the geographic impact of Richard G. Langley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard G. Langley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard G. Langley more than expected).
Fields of papers citing papers by Richard G. Langley
This network shows the impact of papers produced by Richard G. Langley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard G. Langley. The network helps show where Richard G. Langley may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Richard G. Langley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 1 | |
| 7 | 2023 | 1 | |
| 8 | 2023 | 3 | |
| 9 | 2023 | 14 | |
| 10 | 2023 | 9 | |
| 11 | 2023 | 23 | |
| 12 | 2022 | 20 | |
| 13 | 2022 | 6 | |
| 14 | 2022 | 5 | |
| 15 | 2021 | 69 | |
| 16 | 2021 | 21 | |
| 17 | 2020 | 15 | |
| 18 | 2014 | 0 | |
| 19 | 2012 | 296 | |
| 20 | Remittive effects of intramuscular alefacept in psoriasis. | 2003 | 54 |
About Richard G. Langley
Richard G. Langley is a scholar working on Dermatology, Immunology and Immunology and Allergy, having authored 264 papers that have together received 19.1k indexed citations. Recurring topics across this work include Psoriasis: Treatment and Pathogenesis (181 papers), Dermatology and Skin Diseases (120 papers), Asthma and respiratory diseases (50 papers), Autoimmune Bullous Skin Diseases (41 papers), Health Systems, Economic Evaluations, Quality of Life (29 papers), Pharmaceutical studies and practices (26 papers), Autoimmune and Inflammatory Disorders Research (21 papers) and Food Allergy and Anaphylaxis Research (17 papers). The work is most often cited by research in Dermatology (9.6k citations), Immunology (14.7k citations) and Rheumatology (3.4k citations). Richard G. Langley has collaborated with scholars based in Canada, United States and Germany. Frequent co-authors include Kim Papp, Kristian Reich, Mark Lebwohl, Kenneth B. Gordon, Craig L. Leonardi, Charles N. Ellis, Gerald G. Krueger, Alan Menter, Newman Yeilding and C.E.M. Griffiths. Their work appears in journals such as New England Journal of Medicine, The Lancet and JAMA.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.